SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001513160-12-000090
Filing Date
2012-11-21
Accepted
2012-11-21 15:27:48
Documents
9
Period of Report
2012-09-30

Document Format Files

Seq Description Document Type Size
1 OXIS QUARTERLY REPORT oxis10q09302012.htm 10-Q 586915
2 EXHIBIT 31.1 ex311.htm EX-31.1 13083
3 EXHIBIT 32.1 ex321.htm EX-32.1 6112
  Complete submission text file 0001513160-12-000090.txt   2721950

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT oxis-20120930.xml EX-101.INS 337019
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT oxis-20120930.xsd EX-101.SCH 20286
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE oxis-20120930_cal.xml EX-101.CAL 31943
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT oxis-20120930_def.xml EX-101.DEF 41123
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT oxis-20120930_lab.xml EX-101.LAB 158873
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT oxis-20120930_pre.xml EX-101.PRE 117593
Mailing Address 468 N. CAMDEN DR. 2ND FLOOR BEVERLY HILLS CA 90210
Business Address 468 N. CAMDEN DR. 2ND FLOOR BEVERLY HILLS CA 90210 (310) 551-4020
OXIS INTERNATIONAL INC (Filer) CIK: 0000109657 (see all company filings)

IRS No.: 941620407 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-08092 | Film No.: 121221120
SIC: 2834 Pharmaceutical Preparations